Novomedicon ApS: Financial statements 2021
CVR: 38818791
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Novomedicon ApS (CVR 38818791) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -522 compared with DKK -4,643 the year before. Equity in the 2021 report amounted to DKK 34,835. The solvency ratio was 87.2%.
- Profit/Loss
- DKK -522
- Equity
- DKK 34,835
- Total Assets
- DKK 39,947
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -522 | 35K | - |
| 2020 | - | 0 | -5K | -5K | 1 |
| 2019 | - | 0 | 0 | 100 | 1 |
| 2018 | 0 | 0 | 0 | 0 | - |
Official annual report
Find more companies like Novomedicon ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On September 30, 2021, the company changed its name from Novomedicon IVS to Novomedicon ApS.
Novomedicon ApS has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK -4,643.
About Novomedicon ApS
Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.
